Piramal Pharma Solutions unveils in-vitro biology capabilities at Ahmedabad Discovery Services Site
Mumbai : Piramal Pharma Limited’s Pharma Solutions (PPS) business, a Contract Development and Manufacturing Organization (CDMO), has formally announ…
Revise Phase III CT protocol of Olokizumab as a single-arm study: CDSCO Panel Tells Dr Reddys
New Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has opined the drug major Dr …
MCC Releases Final Result For Stray Round Of NEET PG, NEET MDS Counselling, Details
Delhi: The Medical Counselling Committee (MCC) has released the Final Result for the Stray Vacancy Round of NEET PG Counselling 2023 for MD/MS/DIPLO…
CDSCO Accepts Class C and D Medical Device Applications for license Valid for 6 Months
New Delhi: With an aim to avoid disrupting business continuity due to the implementation of the licensing regime with effect from 01.10.2023 for Cl…
Andhra CM Jagan Mohan Reddy to inaugurate pharma units in Visakhapatnam today
Visakhapatnam : Andhra Pradesh Chief Minister YS Jagan Mohan Reddy is all set to visit Visakhapatnam and Anakapalli district on October 16. The …
CDSCO Panel Rejects MSN Laboratories Proposal For Combikit of Silodosin Capsules plus Mirabegron
New Delhi: Highlighting that there is no unmet need for the proposed Combi kit of Silodosin Capsules 8mg/8mg plus Mirabegron extended released (ER)…
Submit Phase III CT Protocol: CDSCO Panel Tells Glenmark Pharmaceuticals on Antidiabetic FDC
New Delhi: Citing that the proposed fixed-dose combination (FDC) of antidiabetic drug Metformin HCl plus Glimepiride plus Lobeglitazone sulfate tab…
